These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2682131)

  • 21. A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade.
    Jaklitsch RR; Westenskow DR
    J Clin Monit; 1990 Jan; 6(1):24-38. PubMed ID: 2404085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New muscle relaxants in outpatient anesthesiology.
    Goldberg M; Rosenberg H
    Dent Clin North Am; 1987 Jan; 31(1):117-29. PubMed ID: 3542610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of the effect of muscle relaxants on the intraocular pressure].
    Jantzen JP; Earnshaw G; Hackett GH; Hilley DM; Giesecke AH
    Anaesthesist; 1987 May; 36(5):223-7. PubMed ID: 2888418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of calcium channel blockers with non-depolarising muscle relaxants in vitro.
    Sekerci S; Tulunay M
    Anaesthesia; 1996 Feb; 51(2):140-4. PubMed ID: 8779369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histamine liberation in surgical patients following administration of neuromuscular blocking drugs.
    Ertama PM
    Ann Clin Res; 1982 Feb; 14(1):15-26. PubMed ID: 6182834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects on non-depolarizing neuromuscular blocking agents on peripheral autonomic mechanisms in cats.
    Hughes R; Chapple DJ
    Br J Anaesth; 1976 Feb; 48(2):59-68. PubMed ID: 130154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of prior administration of suxamethonium on non-depolarising muscle relaxants in the dog.
    Jones RS; Gleed RD
    Res Vet Sci; 1984 Jan; 36(1):43-7. PubMed ID: 6709976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH
    Anesth Analg; 1980 Aug; 59(8):604-9. PubMed ID: 7190795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lithium carbonate and neuromuscular blocking agents.
    Hill GE; Wong KC; Hodges MR
    Anesthesiology; 1977 Feb; 46(2):122-6. PubMed ID: 835845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mixed neuromuscular block: the effect of precurarization.
    Ferguson A; Bevan DR
    Anaesthesia; 1981 Jul; 36(7):661-6. PubMed ID: 7270841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between vecuronium and suxamethonium in the dog.
    Jones RS
    Res Vet Sci; 1986 Jul; 41(1):93-7. PubMed ID: 2876469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of prior administration of a non-depolarising muscle relaxant on the action of suxamethonium in the dog.
    Jones RS; Gleed RD
    Res Vet Sci; 1984 May; 36(3):348-53. PubMed ID: 6463378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.
    Frampton JE; McTavish D
    Drugs; 1993 Jun; 45(6):1066-1089. PubMed ID: 7691494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential potentiation by calcium antagonists of neuromuscular blockade induced by pancuronium and succinylcholine in cats in vivo.
    Ocaña M; Del Pozo E; Carlos R; Baeyens JM
    J Neural Transm Gen Sect; 1992; 88(3):223-34. PubMed ID: 1418860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atracurium and vecuronium: two unique neuromuscular blocking agents.
    Conner CS
    Drug Intell Clin Pharm; 1984 Sep; 18(9):714-6. PubMed ID: 6148226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular effects of vecuronium, atracurium, pancuronium, metocurine and RGH-4201 in dogs.
    Hackett GH; Jantzen JP; Earnshaw G
    Acta Anaesthesiol Scand; 1989 May; 33(4):298-303. PubMed ID: 2566252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromuscular blocking drugs in infants and children.
    Gronert BJ; Brandom BW
    Pediatr Clin North Am; 1994 Feb; 41(1):73-91. PubMed ID: 8295808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring and reversal of neuromuscular block.
    Bevan DR
    Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S10-3. PubMed ID: 10437711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular and neuromuscular effects of Org NC 45, pancuronium, metocurine, and d-tubocurarine in dogs.
    Booij LH; Edwards RP; Sohn YJ; Miller RD
    Anesth Analg; 1980 Jan; 59(1):26-30. PubMed ID: 7188662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.